Similar articles

• Suppression of pancreatic glucagon secretion by tolbutamide in dogs.

  Ohneda A, Sato M, Matsuda K, Itabashi H, Horigome K, Chiba M, Yamagata S. Ohneda A, et al. Horm Metab Res. 1974 Nov;6(6):478-83. doi: 10.1055/s-0028-1093807. Horm Metab Res. 1974. PMID: 4452546 No abstract available.
• Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.

  Gerich JE, Langlois M, Schneider V, Karam JH, Noacco C. Gerich JE, et al. J Clin Invest. 1974 May;53(5):1284-9. doi: 10.1172/JCI107675. J Clin Invest. 1974. PMID: 4825225 Free PMC article.
• Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.

  Kuku SF, Jaspan JB, Emmanouel DS, Katz AI, Rubenstein AH. Kuku SF, et al. Horm Metab Res. 1978 Mar;10(2):99-100. doi: 10.1055/s-0028-1093451. Horm Metab Res. 1978. PMID: 649048
• Excessive glucagon responses to arginine in active acromegaly.

  Goldfine ID, Kirsteins L, Lawrence AM. Goldfine ID, et al. Horm Metab Res. 1972 Mar;4(2):97-100. doi: 10.1055/s-0028-1094076. Horm Metab Res. 1972. PMID: 5063721 No abstract available.
• Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.

  Meister R, Berger I, Schwille PO, Gebhardt C. Meister R, et al. Eur J Surg. 1991 May;157(5):333-40. Eur J Surg. 1991. PMID: 1678647